Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
PharmAla Biotech Logo
PharmAla Biotech Growth Score
70
CB Rank
10097
Heat Score
76
PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.
Founded
obfuscation
PublicPost-IPO Equity Toronto, Ontario, Canada11-50 pharmala.ca/
Biotechnology
Health Care
Manufacturing
Pharmaceutical
Overview

PharmAla Biotech
Total Funding
obfuscation
Growth Score
70
Heat Score
76

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score70
-20 pts
in past quarter
Heat Score 76
11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About PharmAla Biotech

CB Rank
10097
PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.
Founded
obfuscation
PublicPost-IPO Equity Toronto, Ontario, Canada11-50 pharmala.ca/
Biotechnology
Health Care
Manufacturing
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name PharmAla Biotech Inc.
Operating Status Active
Number of Exits 
obfuscation
Stock Symbol  CSE:MDMA
Company Type For Profit
Founders  Nicholas Kadysh
About the Company
PharmAla Biotech is a Canadian biotechnology company that specialises in the research, development, manufacturing, and sales of MDMA substances for the clinical research community. With a focus on advancing scientific understanding, PharmAla Biotech provides high-quality MDMA products and services to support clinical research endeavours.
Phone Number +1 855 444 6362
Contact Email outreach@pharmala.ca
Predictions & Insights

Growth Insight

See this Growth Insight
PharmAla Biotech is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

LaNeo™ MDMA
Clinical-grade MDMA active pharmaceutical ingredient (API) supplied for research and clinical trials under GMP conditions.
Novel MDXX Compounds
Research and development of novel chemical entities based on MDXX molecules aimed at improving safety profiles for therapeutic use.

Research & Development

PharmAla Biotech is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - PharmAla Biotech Logo
Post-IPO Equity - PharmAla Biotech
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Ontario Centre of Innovation Logo
Ontario Centre of Innovation
Yes
Grant - PharmAla Biotech Logo
Grant - PharmAla Biotech
—
Ontario Centre of Innovation Logo
Ontario Centre of Innovation
Yes
Grant - PharmAla Biotech Logo
Grant - PharmAla Biotech
—
Ontario Centre of Innovation Logo
Ontario Centre of Innovation
Yes
Grant - PharmAla Biotech Logo
Grant - PharmAla Biotech
—
Ontario Centre of Innovation Logo
Ontario Centre of Innovation
Yes
Grant - PharmAla Biotech Logo
Grant - PharmAla Biotech
—
Ontario Centre of Innovation Logo
Ontario Centre of Innovation
Yes
Grant - PharmAla Biotech Logo
Grant - PharmAla Biotech
—

Investments

Number of Investments 1
Number of Exits 
obfuscation
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation

Investment Breakdown

Number of Investments 1
Number of Exits 
obfuscation
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
obfuscation
Jupiter Neurosciences Logo
Jupiter Neurosciences
Yes
Post-IPO Equity - Jupiter Neurosciences Logo
Post-IPO Equity - Jupiter Neurosciences
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 2 Contacts 3

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

543
-6.86%
 in past month

IT Spend

$5.8KThis year, PharmAla Biotech is projected to spend $5.8K on IT, according to Aberdeen.

Active Website Tech Count

52PharmAla Biotech is actively using 52 technologies for its website, according to BuiltWith. These include Viewport Meta, SSL by Default, and  IPhone / Mobile Compatible.

Total IP

5The intellectual property of PharmAla Biotech includes 5 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is PharmAla Biotech's headquarters? PharmAla Biotech is located in Toronto, Ontario, Canada.Who invested in PharmAla Biotech? PharmAla Biotech is funded by Ontario Centre of Innovation.When was the last funding round for PharmAla Biotech? PharmAla Biotech closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are PharmAla Biotech's competitors? Alternatives and possible competitors to PharmAla Biotech may include Optimi Health, Beckley Psytech, and  Awakn Life Sciences.How much funding has PharmAla Biotech raised to date? PharmAla Biotech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|